MLA
CLX icon

MB, Levis & Associates’s Clorox CLX Stock Holding History

MB, Levis & Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,095
Closed -$732K – 260
2025
Q2 		$732K Buy
6,095
+194
+3% +$25.9K 0.32% 43
2025
Q1 		$869K Buy
5,901
+51
+0.9% +$7.79K 0.4% 40
2024
Q4 		$950K Buy
5,850
+1
+0% +$164 0.48% 38
2024
Q3 		$953K Sell
5,849
-174
-3% -$25.8K 0.47% 38
2024
Q2 		$822K Buy
6,023
+84
+1% +$11.7K 0.43% 38
2024
Q1 		$909K Buy
5,939
+79
+1% +$11.8K 0.49% 33
2023
Q4 		$836K Buy
5,860
+42
+0.7% +$5.6K 0.48% 33
2023
Q3 		$763K Hold
5,818
– – 0.49% 34
2023
Q2 		$925K Buy
5,818
+28
+0.5% +$4.52K 0.59% 30
2023
Q1 		$916K Buy
5,790
+36
+0.6% +$5.4K 0.64% 30
2022
Q4 		$808K Buy
+5,754
New +$817K 0.63% 29

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MB, Levis & Associates's CLX Position: Q3 2025 in Review

MB, Levis & Associates sold out of Clorox (CLX) in Q3 2025, closing a stake of 6,095 shares — an estimated $732K sold.

MB, Levis & Associates first reported a position in CLX in Q4 2022 and held it in 11 quarters. The position peaked at $953K in Q3 2024. 1,091 funds tracked by Wall St. Rank hold CLX as of Q3 2025.

  • MB, Levis & Associates reported no remaining Clorox position as of Q3 2025 after selling out during the quarter.
  • MB, Levis & Associates sold 6,095 Clorox shares in Q3 2025, an estimated $732K.
  • MB, Levis & Associates first reported a position in Clorox in Q4 2022 and held it in 11 quarters.
  • MB, Levis & Associates's Clorox position peaked at $953K in Q3 2024.
  • 1,091 funds tracked by Wall St. Rank held Clorox as of Q3 2025.

Based on MB, Levis & Associates's 13F filing for Q3 2025, filed 15 Oct 2025.